These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20158106)

  • 1. [PPARgamma agonists as potential therapeutic drugs for allergic diseases].
    Ueki S; Chihara J
    Nihon Rinsho; 2010 Feb; 68(2):335-40. PubMed ID: 20158106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Regulation of allergic immune response of PPARgamma agonists--emerging roles in allergic response].
    Chihara J; Takeda M; Ueki S
    Nihon Rinsho; 2010 Feb; 68(2):261-5. PubMed ID: 20158094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation.
    Belvisi MG; Hele DJ; Birrell MA
    Eur J Pharmacol; 2006 Mar; 533(1-3):101-9. PubMed ID: 16458290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor gamma regulates eosinophil functions: a new therapeutic target for allergic airway inflammation.
    Ueki S; Matsuwaki Y; Kayaba H; Oyamada H; Kanda A; Usami A; Saito N; Chihara J
    Int Arch Allergy Immunol; 2004 Jun; 134 Suppl 1():30-6. PubMed ID: 15166481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor gamma agonist down-regulates IL-17 expression in a murine model of allergic airway inflammation.
    Park SJ; Lee KS; Kim SR; Min KH; Choe YH; Moon H; Chae HJ; Yoo WH; Lee YC
    J Immunol; 2009 Sep; 183(5):3259-67. PubMed ID: 19641141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Protective role of PPARgamma agonists against cardiovascular disease].
    Yamagishi S
    Nihon Rinsho; 2010 Feb; 68(2):307-11. PubMed ID: 20158101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator activated receptor-gamma modulates reactive oxygen species generation and activation of nuclear factor-kappaB and hypoxia-inducible factor 1alpha in allergic airway disease of mice.
    Lee KS; Kim SR; Park SJ; Park HS; Min KH; Jin SM; Lee MK; Kim UH; Lee YC
    J Allergy Clin Immunol; 2006 Jul; 118(1):120-7. PubMed ID: 16815147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of IL-10 in peroxisome proliferator-activated receptor gamma-mediated anti-inflammatory response in asthma.
    Kim SR; Lee KS; Park HS; Park SJ; Min KH; Jin SM; Lee YC
    Mol Pharmacol; 2005 Dec; 68(6):1568-75. PubMed ID: 16150927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [PPARgamma as a new therapeutic target in inflammatory diseases].
    Naito Y; Yoshikawa T
    Nihon Rinsho; 2010 Feb; 68(2):341-9. PubMed ID: 20158107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-inflammatory effect of PPARgamma agonists: basics and clinical applications].
    Wada K; Kamisaki Y
    Nihon Rinsho; 2010 Feb; 68(2):278-83. PubMed ID: 20158097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [PPARgamma agonists for the diseases of gastrointestinal tract and liver].
    Shimada T; Hiraishi H
    Nihon Rinsho; 2010 Feb; 68(2):312-6. PubMed ID: 20158102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components.
    Martin H
    Mutat Res; 2009 Oct; 669(1-2):1-7. PubMed ID: 19563816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of PPARgamma agonists in kidney diseases].
    Yokoyama Y; Doi S; Kawai T; Yorioka N
    Nihon Rinsho; 2010 Feb; 68(2):317-22. PubMed ID: 20158103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARgamma as a therapeutic target in central nervous system diseases.
    Sundararajan S; Jiang Q; Heneka M; Landreth G
    Neurochem Int; 2006 Jul; 49(2):136-44. PubMed ID: 16766086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ketotifen in allergic diseases].
    Huerta López JG
    Rev Alerg; 1991; 38(6):151-7. PubMed ID: 1792482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor gamma as a novel therapeutic target in asthma.
    Park SJ; Lee YC
    J Asthma; 2008; 45(1):1-8. PubMed ID: 18259989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omalizumab: efficacy in allergic disease.
    Spector S
    Panminerva Med; 2004 Jun; 46(2):141-8. PubMed ID: 15507883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor gamma (PPARgamma): Is the genomic activity the only answer?
    Luconi M; Cantini G; Serio M
    Steroids; 2010; 75(8-9):585-94. PubMed ID: 19900469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pleiotropic effects of PPARgamma agonists on bone remodeling].
    Sugiyama E; Hounoki H; Shinoda K; Taki H; Miyahara T
    Nihon Rinsho; 2010 Feb; 68(2):273-7. PubMed ID: 20158096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic.
    Owen CE
    Pharmacol Ther; 2007 Jan; 113(1):121-33. PubMed ID: 17000005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.